Interaction of nutrition and genetics via DNMT3L-mediated DNA methylation determines cognitive decline
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 78, 64-73
Abstract
No abstract availableKeywords
Funding Information
- University of Nottingham
- Medical Research Council
- Charles Wolfson Charitable Trust
- Wellcome Trust
- Medical Research Council
- European Union
- National Institute for Health Research
This publication has 53 references indexed in Scilit:
- Vitamin B12 and the risk of schizophrenia: A meta-analysisSchizophrenia Research, 2016
- Dnmt3a Regulates Global Gene Expression in Olfactory Sensory Neurons and Enables Odorant-Induced TranscriptionNeuron, 2014
- Epigenetic changes in the progression of Alzheimer's diseaseMechanisms of Ageing and Development, 2013
- The future of epigenetic therapy in solid tumours—lessons from the pastNature Reviews Clinical Oncology, 2013
- High-Dose B Vitamin Supplementation and Cognitive Decline in Alzheimer DiseaseJAMA, 2008
- Mild cognitive impairment: applicability of research criteria in a memory clinic and characterization of cognitive profilePsychological Medicine, 2006
- Detecting Dementia: Novel Neuropsychological Markers of Preclinical Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 2003
- Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer's diseasePsychological Medicine, 2003
- Imprinting regulator DNMT3L is a transcriptional repressor associated with histone deacetylase activityNucleic Acids Research, 2002
- CpG-rich islands and the function of DNA methylationNature, 1986